NGL Fine-Chem balance sheet

As of Mar 2026

Total assets: ₹545cr+25.9% on Mar 2025
Shareholders' equity: ₹329cr+16.6% on Mar 2025
Total debt: ₹108cr+48.2% on Mar 2025
Cash and investments: ₹42.0cr−30.3% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023

Non-current assets
	164	142	85.3	87.6
	94.6	49.7	45.5	26.3
	0.2	0.0	0.0	0.0
	0.3	0.5	0.3	0.3
	0.5	0.0	0.0	0.0
	9.4	1.0	8.8	8.7
	9.9	1.0	8.8	8.7
	0.4	4.6	3.0	1.4
	269	198	143	124
Current assets
	70.3	51.3	43.3	27.0
	39.2	59.7	53.6	39.5
	131	81.6	89.6	65.9
	2.8	0.6	0.4	7.8
	2.3	5.3	1.3	5.2
	1.7	8.4	6.2	5.0
	177	155	151	123
	29.2	28.6	18.3	12.3
	276	235	213	163
	545	433	356	287
Equity
	3.1	3.1	3.1	3.1
	326	279	260	219
	329	282	263	223
	329	282	263	223
Liabilities
	56.4	25.3	0.7	2.1
	3.4	—	—	—
	59.8	25.3	0.7	2.1
	4.7	4.0	3.2	2.7
	1.6	2.5	2.2	1.4
	0.2	0.2	0.2	0.1
	66.3	32.0	6.3	6.2
	52.0	47.8	31.7	28.4
	64.6	57.5	49.4	24.6
	28.8	12.2	4.0	3.7
	145	117	85.1	56.7
	1.0	1.5	0.8	0.7
	1.9	—	0.7	0.9
	1.7	—	—	0.0
	150	119	86.6	58.3
	216	151	92.9	64.5
	545	433	356	287
Trade payables — MSME split
	16.8	0.0	—	—
	47.8	57.5	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

NGLFINE₹2,610.60

NGL Fine-Chem Limited

· Pharma & Health

₹ CrorePeersSYNCOMF JAGSNPHARM HESTERBIOAMRUTANJAN WINDLAS INDOCO SAIPARENTMcap ₹1,613 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	87.6	85.3	142.1	163.8	163.8
+ Capital Work-in-Progress	26.3	45.5	49.7	94.6	94.6
+ Goodwill	0.0	0.0	0.0	0.2	0.2
+ Other Intangibles	0.3	0.3	0.5	0.3	0.3
+ Long-term Loans	0.0	0.0	0.0	0.5	0.5
+ Other Non-current Financial Assets	8.7	8.8	1.0	9.4	9.4
Non-current Financial Assets	8.7	8.8	1.0	9.9	9.9
+ Other Non-current Assets	1.4	3.0	4.6	0.4	0.4
Total Non-current Assets	124.4	142.9	198.0	269.1	269.1
Current Assets
+ Inventories	27.0	43.3	51.3	70.3	70.3
+ Current Investments	39.5	53.6	59.7	39.2	39.2
+ Trade Receivables	65.9	89.6	81.6	130.9	130.9
+ Cash & Cash Equivalents	7.8	0.4	0.6	2.8	2.8
+ Other Bank Balances	5.2	1.3	5.3	2.3	2.3
+ Other Current Financial Assets	5.0	6.2	8.4	1.7	1.7
Current Financial Assets	123.4	151.1	155.5	176.9	176.9
+ Other Current Assets	12.3	18.3	28.6	29.2	29.2
Total Current Assets	162.7	212.7	235.4	276.4	276.4
Total Assets	287.1	355.5	433.4	545.5	545.5
Equity
+ Equity Share Capital	3.1	3.1	3.1	3.1	3.1
+ Other Equity / Reserves	219.5	259.5	279.3	326.1	326.1
Equity — Owners of Parent	222.5	262.6	282.4	329.2	329.2
Total Equity	222.5	262.6	282.4	329.2	329.2
Liabilities
+ Borrowings — Non-current	2.1	0.7	25.3	56.4	56.4
+ Other Non-current Financial Liab	—	—	—	3.4	3.4
Non-current Financial Liabilities	2.1	0.7	25.3	59.8	59.8
+ Provisions — Non-current	2.7	3.2	4.0	4.7	4.7
+ Deferred Tax Liabilities	1.4	2.2	2.5	1.6	1.6
+ Other Non-current Liabilities	0.1	0.2	0.2	0.2	0.2
Non-current Liabilities	6.2	6.3	32.0	66.3	66.3
+ Borrowings — Current	28.4	31.7	47.8	52.0	52.0
+ Trade Payables	24.6	49.4	57.5	64.6	64.6
+ Other Current Financial Liab	3.7	4.0	12.2	28.8	28.8
Current Financial Liabilities	56.7	85.1	117.5	145.4	145.4
+ Provisions — Current	0.7	0.8	1.5	1.0	1.0
+ Current Tax Liabilities	0.9	0.7	—	1.9	1.9
+ Other Current Liabilities	0.0	—	—	1.7	1.7
Current Liabilities	58.3	86.6	119.0	150.0	150.0
Total Liabilities	64.5	92.9	151.0	216.3	216.3
Total Equity & Liabilities	287.1	355.5	433.4	545.5	545.5
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	0.0	16.8	16.8
+ Dues to Other Creditors — Current	—	—	57.5	47.8	47.8

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.